Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors
Company Announcements

Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors

The latest announcement is out from Seer (SEER).

Seer, Inc. has appointed Nicolas Henry Roelofs, Ph.D., to its board with his term set to expire at the 2025 annual stockholders’ meeting. Dr. Roelofs will take on the role of Lead Independent Director and contribute to the Corporate Governance and Nominating Committee and Science and Technology Committee. He will be compensated according to the company’s policy for directors and has been granted stock options and restricted stock units that will vest over three years. Dr. Roelofs’ appointment, which is based solely on merit without any undisclosed arrangements, was publicly announced by Seer, Inc. through a press release.

For an in-depth examination of SEER stock, go to TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireSeer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswireSeer Appoints Nicolas Roelofs to its Board of Directors
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!